PLoS ONE (Jan 2023)
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial
- Jonas Sundén-Cullberg,
- Puran Chen,
- Henrike Häbel,
- Paul Skorup,
- Helena Janols,
- Johan Rasmuson,
- Katarina Niward,
- Åse Östholm Balkhed,
- Katerina Chatzidionysiou,
- Hilmir Asgeirsson,
- Ola Blennow,
- Åsa Parke,
- Anna-Karin Svensson,
- Jagadeeswara Rao Muvva,
- Hans-Gustav Ljunggren,
- Anna-Carin Horne,
- Ulrika Ådén,
- Jan-Inge Henter,
- Anders Sönnerborg,
- Jan Vesterbacka,
- Piotr Nowak,
- Jon Lampa
Affiliations
- Jonas Sundén-Cullberg
- Puran Chen
- Henrike Häbel
- Paul Skorup
- Helena Janols
- Johan Rasmuson
- Katarina Niward
- Åse Östholm Balkhed
- Katerina Chatzidionysiou
- Hilmir Asgeirsson
- Ola Blennow
- Åsa Parke
- Anna-Karin Svensson
- Jagadeeswara Rao Muvva
- Hans-Gustav Ljunggren
- Anna-Carin Horne
- Ulrika Ådén
- Jan-Inge Henter
- Anders Sönnerborg
- Jan Vesterbacka
- Piotr Nowak
- Jon Lampa
- Journal volume & issue
-
Vol. 18,
no. 12